459 related articles for article (PubMed ID: 32861617)
21. Clinicopathological characteristics, molecular landscape, and biomarker landscape for predicting the efficacy of PD-1/PD-L1 inhibitors in Chinese population with mismatch repair deficient urothelial carcinoma: a real-world study.
Ma YT; Hua F; Zhong XM; Xue YJ; Li J; Nie YC; Zhang XD; Ma JW; Lin CH; Zhang HZ; He W; Sha D; Zhao MQ; Yao ZG
Front Immunol; 2023; 14():1269097. PubMed ID: 38022513
[TBL] [Abstract][Full Text] [Related]
22. Genomic profiling of Chinese patients with urothelial carcinoma.
Yang B; Zhao X; Wan C; Ma X; Niu S; Guo A; Wang J; Wang J; Sun D; Jiao S
BMC Cancer; 2021 Feb; 21(1):162. PubMed ID: 33588785
[TBL] [Abstract][Full Text] [Related]
23. Synchronous and metachronous urothelial carcinoma of the upper urinary tract and the bladder: Are they clonally related? A systematic review.
van Doeveren T; van de Werken HJG; van Riet J; Aben KKH; van Leeuwen PJ; Zwarthoff EC; Boormans JL
Urol Oncol; 2020 Jun; 38(6):590-598. PubMed ID: 32057596
[TBL] [Abstract][Full Text] [Related]
24. The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Kosaka T; Mizuno R; Mikami S; Kikuchi E; Oya M
Cancer Sci; 2021 Mar; 112(3):1084-1094. PubMed ID: 33368857
[TBL] [Abstract][Full Text] [Related]
25. Mutational Analysis of 472 Urothelial Carcinoma Across Grades and Anatomic Sites.
Nassar AH; Umeton R; Kim J; Lundgren K; Harshman L; Van Allen EM; Preston M; Dong F; Bellmunt J; Mouw KW; Choueiri TK; Sonpavde G; Kwiatkowski DJ
Clin Cancer Res; 2019 Apr; 25(8):2458-2470. PubMed ID: 30593515
[TBL] [Abstract][Full Text] [Related]
26. Molecular intricacies of upper tract urothelial carcinoma and their relevance for therapy considerations.
Berndl F; Hassler MR
Curr Opin Urol; 2022 Jan; 32(1):48-53. PubMed ID: 34772864
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of molecular signatures in the urinary bladder and upper tract urothelial carcinomas: a prospective controlled clinical study.
Dawood EE; Awadalla A; Hashem A; Shokeir AA; Abdel-Aziz AF
J Egypt Natl Canc Inst; 2022 Nov; 34(1):47. PubMed ID: 36372809
[TBL] [Abstract][Full Text] [Related]
28. Profiling the Biological Characteristics and Transitions through Upper Tract Tumor Origin, Bladder Recurrence, and Muscle-Invasive Bladder Progression in Upper Tract Urothelial Carcinoma.
Shigeta K; Matsumoto K; Tanaka N; Mikami S; Kosaka T; Yasumizu Y; Takeda T; Mizuno R; Kikuchi E; Oya M
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563543
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological Features of FGFR3 - Mutated Upper Tract Urothelial Carcinoma: A Genomic Database Analysis.
Rizzo A; Mollica V; Santoni M; Massari F
Clin Genitourin Cancer; 2022 Oct; 20(5):482-487. PubMed ID: 35858936
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)-Deficient Carcinomas of the Urinary System.
Gupta S; Albertson D; Gaston D; Heilbrun ME; Agarwal N; Boucher K; Parnell TJ; Liu T; Morgans A; Madison R; Gowen K; Miller VA; Ross JS; Ali SM; Millis SZ
Clin Genitourin Cancer; 2018 Apr; 16(2):e373-e382. PubMed ID: 28974397
[TBL] [Abstract][Full Text] [Related]
31. Genomic profile - a possible diagnostic and prognostic marker in upper tract urothelial carcinoma.
Grahn A; Eisfeldt J; Malm C; Foroughi Asl H; Jaremko G; Tham E; Brehmer M
BJU Int; 2022 Jul; 130(1):92-101. PubMed ID: 34375486
[TBL] [Abstract][Full Text] [Related]
32. High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder.
Lee YE; Chan TC; Tian YF; Liang PI; Shiue YL; Chen YS; He HL
Urol Oncol; 2019 May; 37(5):299.e7-299.e18. PubMed ID: 30660494
[TBL] [Abstract][Full Text] [Related]
33. Genomic landscape of locally advanced or metastatic urothelial carcinoma with squamous differentiation compared to pure urothelial carcinoma.
Tripathi N; Jo Y; Tripathi A; Sayegh N; Li H; Nussenzveig R; Haaland B; Thomas VM; Gupta S; Maughan BL; Swami U; Pal SK; Grivas P; Agarwal N; Sirohi D
Urol Oncol; 2022 Nov; 40(11):493.e1-493.e7. PubMed ID: 35918248
[TBL] [Abstract][Full Text] [Related]
34. IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.
Liang PI; Wang YH; Wu TF; Wu WR; Liao AC; Shen KH; Hsing CH; Shiue YL; Huang HY; Hsu HP; Chen LT; Lin CY; Tai C; Wu JY; Li CF
J Clin Pathol; 2013 Jul; 66(7):573-82. PubMed ID: 23539739
[TBL] [Abstract][Full Text] [Related]
35. Comparative Genomic Landscape of Urothelial Carcinoma of the Bladder Among Patients of East and South Asian Genomic Ancestry.
Peak T; Spiess PE; Li R; Grivas P; Necchi A; Pavlick D; Huang RSP; Lin D; Danziger N; Jacob JM; Bratslavsky G; Ross JS
Oncologist; 2023 Oct; 28(10):e910-e920. PubMed ID: 37196060
[TBL] [Abstract][Full Text] [Related]
36. Spectrum of genomic alterations in FGFR3: current appraisal of the potential role of FGFR3 in advanced urothelial carcinoma.
Sethakorn N; O'Donnell PH
BJU Int; 2016 Nov; 118(5):681-691. PubMed ID: 27271022
[TBL] [Abstract][Full Text] [Related]
37. Molecular classification and diagnostics of upper urinary tract urothelial carcinoma.
Fujii Y; Sato Y; Suzuki H; Kakiuchi N; Yoshizato T; Lenis AT; Maekawa S; Yokoyama A; Takeuchi Y; Inoue Y; Ochi Y; Shiozawa Y; Aoki K; Yoshida K; Kataoka K; Nakagawa MM; Nannya Y; Makishima H; Miyakawa J; Kawai T; Morikawa T; Shiraishi Y; Chiba K; Tanaka H; Nagae G; Sanada M; Sugihara E; Sato TA; Nakagawa T; Fukayama M; Ushiku T; Aburatani H; Miyano S; Coleman JA; Homma Y; Solit DB; Kume H; Ogawa S
Cancer Cell; 2021 Jun; 39(6):793-809.e8. PubMed ID: 34129823
[TBL] [Abstract][Full Text] [Related]
38. The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder.
van Doeveren T; Nakauma-Gonzalez JA; Mason AS; van Leenders GJLH; Zuiverloon TCM; Zwarthoff EC; Meijssen IC; van der Made AC; van der Heijden AG; Hendricksen K; van Rhijn BWG; Voskuilen CS; van Riet J; Dinjens WNM; Dubbink HJ; van de Werken HJG; Boormans JL
Int J Cancer; 2021 Feb; 148(4):981-987. PubMed ID: 33006377
[TBL] [Abstract][Full Text] [Related]
39. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
[TBL] [Abstract][Full Text] [Related]
40. Aristolochic acid-associated urinary tract cancers: an updated meta-analysis of risk and oncologic outcomes after surgery and systematic review of molecular alterations observed in human studies.
Kang YC; Chen MH; Lin CY; Lin CY; Chen YT
Ther Adv Drug Saf; 2021; 12():2042098621997727. PubMed ID: 33815744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]